Chronische Nierenerkrankung (CKD) is a progressive condition that affects millions of people worldwide. In its late stages, CKD can lead to kidney failure, requiring dialysis or a kidney transplant. Stammzelltherapie has emerged as a potential treatment option for late-stage CKD, offering hope for patients with this debilitating condition.
Late-Stage Chronic Kidney Disease: An Overview
Late-stage CKD is characterized by a significant decline in kidney function, often leading to a buildup of toxins and fluid in the body. This can cause a range of symptoms, including fatigue, nausea, swelling, and difficulty concentrating. As the disease progresses, patients may experience kidney failure, requiring dialysis or a kidney transplant to survive.
Stammzelltherapie: A Potential Treatment Option
Stem cells are unspecialized cells that have the ability to differentiate into various cell types, including kidney cells. Researchers believe that Stammzelltherapie could potentially regenerate damaged kidney tissue and restore kidney function in patients with late-stage CKD.
